Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Timber Pharmaceuticals Inc (TMBR)

1.91   -0.31 (-13.96%) 03-03 16:27
Open: 2.17 Pre. Close: 2.22
High: 2.23 Low: 1.86
Volume: 3,060,063 Market Cap: 23M
Timber Pharmaceuticals, Inc., formerly BioPharmX Corporation, is a biopharmaceutical company. The Company is focused on the development and commercialization of treatments for orphan dermatologic diseases. It is developing treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its pipeline includes TMB-001, TMB-002 and TMB-003. TMB-001 is a topical isotretinoin, which is being developed for the treatment of moderate to severe subtypes of CI. TMB-002, a topical rapamycin, is being developed for the treatment of facial angiofibromas (FAs) in TSC. TMB-003 is a topical / subcutaneous ET-A receptor antagonist, which is being developed for localized scleroderma.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.283 - 2.294 2.294 - 2.305
Low: 1.99 - 2.003 2.003 - 2.015
Close: 2.194 - 2.216 2.216 - 2.238

Technical analysis

as of: 2021-03-03 4:10:07 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.77     One year: 3.68
Support: Support1: 1.12    Support2: 0.93
Resistance: Resistance1: 2.37    Resistance2: 3.15
Pivot: 2.16
Moving Average: MA(5): 2.04     MA(20): 1.98
MA(100): 1.21     MA(250): 2.06
MACD: MACD(12,26): 0.19     Signal(9): 0.23
Stochastic oscillator: %K(14,3): 42.52     %D(3): 40.96
RSI: RSI(14): 52.29
52-week: High: 10.44  Low: 0.67  Change(%): -63.9
Average Vol(K): 3-Month: 755636  10-Days: 569295

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
TMBR has closed above bottom band by 34.2%. Bollinger Bands are 124.8% wider than normal. The large width of the bands suggest high volatility as compared to TMBR's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.

Headline News

Tue, 02 Mar 2021
Do Analysts Agree Tuesday on Timber Pharmaceuticals Inc (TMBR) Stock's Target Price? - InvestorsObserver

Mon, 01 Mar 2021
Should You Buy Timber Pharmaceuticals Inc (TMBR) Stock on Monday? - InvestorsObserver

Wed, 24 Feb 2021
Premarket Mover: Timber Pharmaceuticals Inc (TMBR) Up 9.76% - InvestorsObserver

Mon, 22 Feb 2021
Timber Pharmaceuticals Inc (TMBR) Stock Declines -19.15% This Week; Should You Buy? - InvestorsObserver

Thu, 11 Feb 2021
Timber Pharmaceuticals Inc (TMBR) Up 27.13% in Premarket Trading - InvestorsObserver

Tue, 02 Feb 2021
Should You Buy Timber Pharmaceuticals Inc (TMBR) Stock Tuesday? - InvestorsObserver

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Underperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12
Shares Float (M) 4
% Held by Insiders
% Held by Institutions
Shares Short (K) 850
Shares Short P. Month (K) 792

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -5341.09
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) -0.254
Sales Per Share 0.029
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 66.63
Price to Cash Flow -3.77

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.